When CART cells were STING-L-deficient, the death proportion due to distal tumor outgrowth increased, reaffirming the impaired antitumor efficacy of STING-KO CART cells and the key role of CART-gp75 cells in the long-term control of small tumors. The gene discussed is STING1; the disease is neoplasm.